Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 198 UK diagnostics and biomarkers companies below.
Chemical reagents and contract manufacturing for pharma and diagnostics supply chains
Biosynth Limited is the UK manufacturing and research entity of Biosynth, a global life sciences reagents and contract development and manufacturing organisation. Its Compton,…
AI-powered infrared diagnostic test for breast cancer recurrence risk
Digistain is a biotechnology company developing MHRA-cleared diagnostic technology for predicting breast cancer recurrence risk. The platform uses infrared spectrometry to…
In vitro diagnostic reagents, test kits and analysers for clinical laboratories
Fortress Diagnostics is a Northern Ireland-based manufacturer of in vitro diagnostic products, supplying clinical chemistry reagents, immunoassays, haematology reagents,…
AI-powered rare disease case finding for primary care
Mendelian is a digital health software company developing AI-driven tools to support the earlier diagnosis of rare diseases in primary care. Its core product is a Class 1…
Automated molecular diagnostics for HLA typing and blood group testing
MC Diagnostics is a specialist molecular diagnostics company developing and manufacturing automated multiplexed assay solutions for clinical and reference laboratories. The…
Ultra-sensitive DNA detection platform
InvenireX is developing a nucleic acid detection platform that uses programmable DNA nanostructures captured within microfluidic chips, read by a proprietary AI-powered imaging…
Lyophilisation equipment, CDMO services, and freeze-drying expertise
Biopharma Group is a contract development and manufacturing organisation and capital equipment supplier specialising in lyophilisation and liquid formulation technologies. The…
Single-molecule counting point-of-care diagnostics for cardiac and other biomarkers
Psyros Diagnostics develops a point-of-care diagnostic system using single-molecule counting technology to measure biomarkers at extremely low concentrations within around ten…
Contract proteomics CRO and inventor of TMT isobaric mass tags
Proteome Sciences is a contract proteomics organisation and reagent manufacturer specialising in mass spectrometry-based protein biomarker discovery, validation, and targeted…
Non-invasive oral cancer screening using genomics and cell-free DNA
Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with…
AI-powered cancer biomarker profiling from tissue images
Panakeia is an AI diagnostics company developing software that predicts molecular biomarker status directly from standard H&E-stained tissue images. Its CE-marked and…
Non-invasive deep lung breath sampling device for molecular research
PulmoBioMed is a medical technology company developing a handheld device for collecting exhaled breath condensate from the lower respiratory tract without contamination from the…